Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Identification of blood exosomal metabolomic profiling for high-altitude cerebral edema.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • الموضوع:
    • نبذة مختصرة :
      High-altitude cerebral edema (HACE) is a severe neurological condition that can occur at high altitudes. It is characterized by the accumulation of fluid in the brain, leading to a range of symptoms, including severe headache, confusion, loss of coordination, and even coma and death. Exosomes play a crucial role in intercellular communication, and their contents have been found to change in various diseases. This study analyzed the metabolomic characteristics of blood exosomes from HACE patients compared to those from healthy controls (HCs) with the aim of identifying specific metabolites or metabolic pathways associated with the development of HACE conditions. A total of 21 HACE patients and 21 healthy controls were recruited for this study. Comprehensive metabolomic profiling of the serum exosome samples was conducted using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC‒MS/MS). Additionally, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was performed to identify the metabolic pathways affected in HACE patients. Twenty-six metabolites, including ( +)-camphoric acid, choline, adenosine, adenosine 5'-monophosphate, deoxyguanosine 5'-monophosphate, guanosine, and hypoxanthine-9-β-D-arabinofuranoside, among others, exhibited significant changes in expression in HACE patients compared to HCs. Additionally, these differentially abundant metabolites were confirmed to be potential biomarkers for HACE. KEGG pathway enrichment analysis revealed several pathways that significantly affect energy metabolism regulation (such as purine metabolism, thermogenesis, and nucleotide metabolism), estrogen-related pathways (the estrogen signaling pathway, GnRH signaling pathway, and GnRH pathway), cyclic nucleotide signaling pathways (the cGMP-PKG signaling pathway and cAMP signaling pathway), and hormone synthesis and secretion pathways (renin secretion, parathyroid hormone synthesis, secretion and action, and aldosterone synthesis and secretion). In patients with HACE, adenosine, guanosine, and hypoxanthine-9-β-D-arabinofuranoside were negatively correlated with height. Deoxyguanosine 5'-monophosphate is negatively correlated with weight and BMI. Additionally, LPE (18:2/0:0) and pregnanetriol were positively correlated with age. This study identified potential biomarkers for HACE and provided valuable insights into the underlying metabolic mechanisms of this disease. These findings may lead to potential targets for early diagnosis and therapeutic intervention in HACE patients.
      (© 2024. The Author(s).)
    • References:
      Nat Rev Mol Cell Biol. 2020 Jul;21(7):363-383. (PMID: 32231263)
      Int J Mol Sci. 2021 Nov 26;22(23):. (PMID: 34884604)
      JAMA. 1998 Dec 9;280(22):1920-5. (PMID: 9851477)
      Int J Mol Sci. 2020 Jun 21;21(12):. (PMID: 32575812)
      Mol Cancer. 2019 Apr 2;18(1):75. (PMID: 30940145)
      Respir Med. 2018 Dec;145:145-152. (PMID: 30509704)
      FEBS J. 2021 Jun;288(12):3746-3771. (PMID: 33825330)
      Am J Physiol Cell Physiol. 2011 Jul;301(1):C204-12. (PMID: 21471464)
      Oncogene. 2019 Jun;38(26):5158-5173. (PMID: 30872795)
      Curr Neuropharmacol. 2019;17(9):874-890. (PMID: 30520375)
      Travel Med Infect Dis. 2014 Jan-Feb;12(1):29-39. (PMID: 24393671)
      Endocrine. 2006 Apr;29(2):209-15. (PMID: 16785597)
      Curr Protoc Bioinformatics. 2019 Dec;68(1):e86. (PMID: 31756036)
      J Inflamm Res. 2023 Jun 23;16:2645-2660. (PMID: 37383357)
      Wilderness Environ Med. 2021 Mar;32(1):88-91. (PMID: 33516622)
      Cell Metab. 2021 Sep 7;33(9):1744-1762. (PMID: 34496230)
      Int J Environ Res Public Health. 2021 Aug 05;18(16):. (PMID: 34444030)
      Mol Psychiatry. 2013 Jan;18(1):67-78. (PMID: 22024767)
      J Cereb Blood Flow Metab. 2006 Oct;26(10):1234-49. (PMID: 16421506)
      Cancer Biol Ther. 2019;20(7):1017-1028. (PMID: 30983515)
      Neural Regen Res. 2013 Nov 5;8(31):2932-41. (PMID: 25206614)
      Autophagy. 2024 Jan;20(1):4-14. (PMID: 37594406)
      J Transl Med. 2023 Apr 3;21(1):241. (PMID: 37009888)
      J Mol Cell Biol. 2022 Sep 19;14(5):. (PMID: 35704676)
      Biochem Biophys Rep. 2018 May 02;14:104-113. (PMID: 29872742)
      Antioxidants (Basel). 2022 Jan 28;11(2):267. (PMID: 35204150)
      Schizophr Bull. 2021 Apr 29;47(3):615-623. (PMID: 33159208)
      Glia. 2005 Jun;50(4):389-397. (PMID: 15846797)
      Comput Struct Biotechnol J. 2022 Oct 25;20:5935-5951. (PMID: 36382190)
      Cochrane Database Syst Rev. 2018 Jun 30;6:CD009567. (PMID: 29959871)
      Cureus. 2023 Feb 14;15(2):e34997. (PMID: 36938238)
      Fluids Barriers CNS. 2022 Jul 25;19(1):60. (PMID: 35879759)
      J Mol Endocrinol. 2020 Apr;64(3):145-154. (PMID: 31958319)
      Physiol Behav. 2017 Mar 15;171:187-191. (PMID: 28069461)
      Redox Biol. 2022 Feb;49:102228. (PMID: 34979449)
      J Appl Physiol (1985). 2021 Jul 1;131(1):313-325. (PMID: 33856254)
    • Contributed Indexing:
      Keywords: Blood; Exosome; High-altitude cerebral edema (HACE); Metabolomics
    • الموضوع:
      Date Created: 20240521 Date Completed: 20240521 Latest Revision: 20240524
    • الموضوع:
      20240524
    • الرقم المعرف:
      PMC11109199
    • الرقم المعرف:
      10.1038/s41598-024-62360-0
    • الرقم المعرف:
      38773195